Bone graft substitutes as drug-device combination products

G. Koller; B. Buranawat; L. Di Silvio

doi:10.1533/9781845697488.2.230

Bone graft substitutes as drug-device combination products

G. Koller, B. Buranawat, L. Di Silvio^*

^*Corresponding author for this work

Centre for Oral, Clinical & Translational Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Delivery of localised growth factors is gaining importance as a future therapeutic tool for regeneration and bone repair. Conventional biomaterials and novel ones are being developed with dual functions; primarily to act as drug combination devices for cells and delivery of therapeutic agents. This chapter addresses some of these systems.

Original language	English
Title of host publication	Drug-Device Combination Products: Delivery Technologies and Applications
Publisher	Elsevier Science Ltd
Pages	230-245
Number of pages	16
ISBN (Print)	9781845694708
DOIs	https://doi.org/10.1533/9781845697488.2.230
Publication status	Published - Dec 2009

Access to Document

10.1533/9781845697488.2.230

Cite this

@inbook{598947aff4d34c109e5370f85ed92c52,

title = "Bone graft substitutes as drug-device combination products",

abstract = "Delivery of localised growth factors is gaining importance as a future therapeutic tool for regeneration and bone repair. Conventional biomaterials and novel ones are being developed with dual functions; primarily to act as drug combination devices for cells and delivery of therapeutic agents. This chapter addresses some of these systems.",

author = "G. Koller and B. Buranawat and {Di Silvio}, L.",

year = "2009",

month = dec,

doi = "10.1533/9781845697488.2.230",

language = "English",

isbn = "9781845694708",

pages = "230--245",

booktitle = "Drug-Device Combination Products: Delivery Technologies and Applications",

publisher = "Elsevier Science Ltd",

}

TY - CHAP

T1 - Bone graft substitutes as drug-device combination products

AU - Koller, G.

AU - Buranawat, B.

AU - Di Silvio, L.

PY - 2009/12

Y1 - 2009/12

N2 - Delivery of localised growth factors is gaining importance as a future therapeutic tool for regeneration and bone repair. Conventional biomaterials and novel ones are being developed with dual functions; primarily to act as drug combination devices for cells and delivery of therapeutic agents. This chapter addresses some of these systems.

AB - Delivery of localised growth factors is gaining importance as a future therapeutic tool for regeneration and bone repair. Conventional biomaterials and novel ones are being developed with dual functions; primarily to act as drug combination devices for cells and delivery of therapeutic agents. This chapter addresses some of these systems.

UR - http://www.scopus.com/inward/record.url?scp=84903329726&partnerID=8YFLogxK

U2 - 10.1533/9781845697488.2.230

DO - 10.1533/9781845697488.2.230

M3 - Chapter

AN - SCOPUS:84903329726

SN - 9781845694708

SP - 230

EP - 245

BT - Drug-Device Combination Products: Delivery Technologies and Applications

PB - Elsevier Science Ltd

ER -

Bone graft substitutes as drug-device combination products

Abstract

Access to Document

Other files and links

Fingerprint

Cite this